William Blair & Company
TRIB

William Blair & Company’s Trinity Biotech TRIB Stock Holding History

William Blair & Company’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-184
Closed -$324K – 1243
2015
Q4 		$324K Buy
184
+12
+7% +$21.2K ﹤0.01% 931
2015
Q3 		$295K Sell
172
-4,949
-97% -$11.9M ﹤0.01% 1148
2015
Q2 		$13.9M Sell
5,121
-12
-0.2% -$31.2K 0.02% 781
2015
Q1 		$14.8M Buy
5,133
+1,114
+28% +$3.09M 0.02% 723
2014
Q4 		$10.6M Buy
4,019
+51
+1% +$132K 0.02% 833
2014
Q3 		$10.9M Sell
3,968
-215
-5% -$698K 0.02% 806
2014
Q2 		$14.4M Sell
4,183
-116
-3% -$412K 0.02% 711
2014
Q1 		$15.6M Sell
4,299
-210
-5% -$826K 0.03% 660
2013
Q4 		$17M Sell
4,509
-1,270
-22% -$4.57M 0.03% 590
2013
Q3 		$18.9M Buy
5,779
+964
+20% +$2.82M 0.03% 524
2013
Q2 		$12.2M Buy
+4,815
New +$12M 0.02% 639

Other funds holding TRIB

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

William Blair & Company's TRIB Position: Q1 2016 in Review

William Blair & Company sold out of Trinity Biotech (TRIB) in Q1 2016, closing a stake of 184 shares — an estimated $324K sold.

William Blair & Company first reported a position in TRIB in Q2 2013 and held it in 11 quarters. The position peaked at $18.9M in Q3 2013. 79 funds tracked by Wall St. Rank hold TRIB as of Q1 2016.

  • William Blair & Company reported no remaining Trinity Biotech position as of Q1 2016 after selling out during the quarter.
  • William Blair & Company sold 184 Trinity Biotech shares in Q1 2016, an estimated $324K.
  • William Blair & Company first reported a position in Trinity Biotech in Q2 2013 and held it in 11 quarters.
  • William Blair & Company's Trinity Biotech position peaked at $18.9M in Q3 2013.
  • 79 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2016.

Based on William Blair & Company's 13F filing for Q1 2016, filed 16 May 2016.